Tags
2010 Access Accessibility accessible. Announces auctions best Business Cool Course Create Design Development Email Free from guide Guidelines Html images Internet Javascript Latest Learn Marketing News Newsletter Nice Online photos Reviews send services Site Software Standards templates Testing Tips Training Tutorial Usability User Using website-
Popular Posts
- Dreamweaver CS4 Tutorial – 11 – CSS of Block Elements 8 comment(s)
- How do you send a html newsletter through Outlook mail? 2 comment(s)
- HIV Testing Would Reveal Many Undiagnosed Cases. 0 comment(s)
- 500 Million IP Smart Object Network Devices by 2016 0 comment(s)
- The Power Of Integration 0 comment(s)
-
Recent Posts
- The Power Of Integration
- Social Media for Research: Not Quite There
- 500 Million IP Smart Object Network Devices by 2016
- Free HTML Email Templates: Bulk Email Sending Tips
- MacMall.com Coupons Featured on CouponBuzz.com Can Save Up to $650 OFF the Apple MacBook Air
- Will Genomic Health’s Next Quarter Be a Bomb?
- AlphaMicron, Inc. Launches the E-Tint
- Cool Web Design Usability images
- NEXSI 8000 CSS RECEIVES FULL VPNC CERTIFICATION.: An article from: Networks Update
- Perminova Names Medical Technology Entrepreneur Michael Perry to Board of Advisors
Blogroll
Tag Archives: Europe
Appcelerator Expands Into Europe with New U.K. Office and Strengthens Management Team with Mobile Industry Executives
Mountain View, Calif. (PRWEB) January 19, 2012
Appcelerator
Posted in companies
Tagged Appcelerator, Europe, Executives, Expands, Industry, Into, Management, Mobile, Office, Strengthens, Team, U.K.
Leave a comment
Research and Markets : Key Process Patents for Erythropoietin Expired in Europe and the US in Late 2004 Opening the Market for Potential Generic Competition
Dublin (PRWEB) May 5, 2005
Research and Markets (http://www.researchandmarkets.com/reports/c16764) has announced the addition of Erythropoietin Current Market Dynamics & Future Outlook to their offering.
At the end of 2004 the world market for erythropoietin was valued at $ 11.1 billion, a growth of 8% over 2003. The market has been growing at an average annual growth rate of 18% over the previous 5 years.
The market for Erythropoietin is very lucrative. Marketing costs are low due to the well-defined patient population and distribution costs are low due to the limited distribution outlets. Since the market is a virtual oligopoly barriers to entry are high thus insuring high profitability.